Galileo Life Sciences, Inc. Retained Earnings
Galileo Life Sciences, Inc. had Retained Earnings of -$2.24 million as of 2015-03-31, per its 10-Q filed 2016-04-01.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2016-04-01
- 2014-06-30: Retained Earnings (Accumulated Deficit) -833.28K CAD.
- 2013-06-30: Retained Earnings (Accumulated Deficit) -585.04K CAD.
CAD
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2014-06-30 | -833.28K CAD 10-K · filed 2014-11-20 |
| 2013-06-30 | -585.04K CAD 10-K · filed 2014-11-20 |
USD
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2015-03-31 | -$2.24M 10-Q · filed 2016-04-01 |
| 2014-12-31 | -$2.05M 10-Q · filed 2016-02-22 |
| 2014-06-30 | -$833.28K 10-Q · filed 2016-04-01 |